Search

Your search keyword '"Nakajima, Kenzaburo"' showing total 229 results

Search Constraints

Start Over You searched for: Author "Nakajima, Kenzaburo" Remove constraint Author: "Nakajima, Kenzaburo"
229 results on '"Nakajima, Kenzaburo"'

Search Results

7. Significance of effective cardiac resynchronization therapy pacing for clinical responses: An analysis based on the effective cardiac resynchronization therapy algorithm

8. Abstract 13558: Age-Dependent Change of Electrocardiographic Characteristics and Cardiac Events in the Long QT Syndrome Type-3 With E1784K Mutation of SCN5A

12. Significance of abnormal and late ventricular signals in ventricular tachycardia ablation of ischemic and nonischemic cardiomyopathies

14. Explainable localization of premature ventricular contraction using deep learning‐based semantic segmentation of 12‐lead electrocardiogram.

16. Prognosis and Outcomes of Clinically Diagnosed Cardiac Sarcoidosis Without Positive Endomyocardial Biopsy Findings

18. Abstract 11307: Longer Outflow Tract Conduction Time by Magnetocardiography as a Novel Non-Invasive Maker for Predicting Lethal Events in Patients With Brugada Syndrome Without Ventricular Fibrillation

20. Relationship between electrical gaps after Maze procedure and atrial tachyarrhythmias and ablation outcomes after cardiac surgery and concomitant Maze procedure

22. Implantable loop recorder uncovered torsades de pointes in long-QT syndrome type 1 with multi cause of syncope.

25. Implications of Ventricular Arrhythmia After Cardiac Resynchronization Therapy

27. Transvenous lead extraction versus surgical lead extraction or conservative treatment for cardiac implantable electronic device infections: Propensity score‐weighted analyses of a nationwide claim‐based database

28. Interference of cardiac implantable electronic devices and computed tomography imaging in the current era with a phantom model

29. PO-02-018 SIGNIFICANCE OF VENTRICULAR ARRHYTHMIA SUBSTRATE AS A PROGNOSTIC MARKER OF CARDIAC RESYNCHRONIZATION THERAPY

30. PO-05-139 CARDIAC SARCOIDOSIS MEETING DIAGNOSTIC CRITERIA FOR ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY: PREVALENCE, CHARACTERISTICS, AND DIFFERENTIATION FROM HEREDITARY ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY

31. PO-05-151 A COMBINATION OF LOW-DOSE QUINIDINE AND VERAPAMIL FOR MULTIFOCAL ECTOPIC PURKINJE-RELATED PREMATURE CONTRACTIONS IN A CASE WITH SCN5A MUTATION

32. PO-01-177 LONG-TERM PROGNOSIS OF PATIENTS WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA IN JAPAN

33. Clinical Predictors of Pacing Device Implantation in Implantable Cardiac Monitor Recipients for Unexplained Syncope

34. Impact of Synchronized Left Ventricular Pacing in Cardiac Resynchronization Therapy

35. Adding interactive face-to-face lectures to passive lectures effectively reduces radiation exposure during atrial fibrillation ablation

36. Real-world comparison of in-hospital complications after catheter ablation for atrial fibrillation between non-antivitamin K anticoagulants and warfarin: A propensity-matched analysis using nation-wide database

37. Differences in patient characteristics, clinical practice and outcomes of cardiac implantable electric device therapy between Japan and the USA: a cross-sectional study using data from nationally representative administrative databases

38. Multicenter Study of the Validity of Additional Freeze Cycles for Cryoballoon Ablation in Patients With Paroxysmal Atrial Fibrillation: The AD-Balloon Study

39. A multicenter prospective randomized study comparing the incidence of periprocedural cerebral embolisms caused by catheter ablation of atrial fibrillation between cryoballoon and radiofrequency ablation (Embo‐Abl study): Study design

40. Impact of Pre-Ablation Direct Current Cardioversion for Persistent Atrial Fibrillation to Predict Recurrence of Atrial Fibrillation after Catheter Ablation

41. Step by Step through the Years—High vs. Low Energy Lead Extraction Using Advanced Extraction Techniques

42. Gene-Based Risk Stratification for Cardiac Disorders in LMNA Mutation Carriers

43. Abstract 21144: Gene-Based Risk Stratification for Cardiac Disorders in LMNA Mutation Carriers in Japan

44. A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio

Catalog

Books, media, physical & digital resources